Shanghai Juncell Therapeutics

This early-stage study is testing a personalized treatment for adults with brain glioma who have no other standard options. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab, and then infuse them back into the patient. The main goals ar…

This early-stage study is testing a personalized immune therapy for people with advanced liver, bile duct, or pancreatic cancers that haven't responded to standard treatments. Doctors take a sample of a patient's tumor, grow special cancer-fighting immune cells from it in a lab, …

This early-phase study is testing the safety and effectiveness of a personalized immune cell therapy for adults with advanced solid tumors that have not responded to standard treatments. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab…

This early-stage study tests whether a personalized immune cell therapy can help control advanced melanoma. Doctors take immune cells from a patient's own tumor, grow large numbers of them in a lab, then infuse them back into the patient after mild chemotherapy. The study aims to…

This early-stage study is testing a new type of personalized cell therapy called GC203 TIL in adults with advanced solid tumors that have stopped responding to standard treatments. Doctors take a patient's own immune cells from a tumor, modify them in a lab to potentially fight c…

This study is testing a personalized treatment for advanced melanoma, a serious skin cancer. It compares a new therapy, where a patient's own immune cells are grown in a lab and reinfused, against standard chemotherapy. The goal is to see if this cell therapy can better control t…

This early-stage study is testing a personalized treatment for advanced breast cancer. Doctors take a patient's own immune cells from a tumor sample, grow large numbers of them in a lab, and then infuse them back into the patient. The goal is to see if this 'TIL therapy' is safe …

This early-stage study is testing whether specially engineered immune cells can help control advanced pancreatic cancer. Doctors take immune cells from a patient's own tumor, modify them in the lab to potentially fight cancer better, then infuse them back into the patient. The tr…

This early-stage study is testing a personalized treatment called TIL therapy for people with advanced gastrointestinal cancers that have come back or stopped responding to standard treatments. Doctors take a sample of a patient's tumor, grow special immune cells from it in a lab…

This early-phase study is testing a new type of cell therapy called GC201 TIL for patients with advanced gynecologic tumors who have run out of standard treatment options. Doctors take a patient's own immune cells from a tumor sample, genetically modify them in the lab to better …

This early-stage study is testing the safety and initial effectiveness of a personalized cell therapy called GC101 TIL for adults with advanced non-small cell lung cancer. Doctors take a patient's own tumor-fighting immune cells, grow large numbers of them in a lab, and then infu…

This early study tests a new immune cell therapy for people with advanced solid tumors who haven't responded to standard treatments. Doctors collect and grow tumor-fighting immune cells from each patient's own tumor, modify them, and infuse them back into the patient. The study a…